APA (7th ed.) Citation

VJ, C., R, O., R, Y., E, G., & AM, R. (2026). Ultra-rare TP53 and KRAS variants predict survival in ICI-treated solid tumours. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04319-3

Chicago Style (17th ed.) Citation

VJ, Clemente-Suárez, Olivares R, Yáñez-Sepúlveda R, Guzmán-Muñóz E, and Rodríguez AM. "Ultra-rare TP53 and KRAS Variants Predict Survival in ICI-treated Solid Tumours." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04319-3.

MLA (9th ed.) Citation

VJ, Clemente-Suárez, et al. "Ultra-rare TP53 and KRAS Variants Predict Survival in ICI-treated Solid Tumours." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04319-3.